Circulating microRNAs in plasma of patients with gastric cancers
暂无分享,去创建一个
D. Ichikawa | E. Otsuji | A. Shiozaki | H. Fujiwara | T. Kosuga | S. Komatsu | K. Okamoto | H. Konishi | R Morimura | S Komatsu | D Ichikawa | H Takeshita | M Tsujiura | H Konishi | A Shiozaki | K Okamoto | E Otsuji | H Fujiwara | T Kosuga | K Deguchi | H. Takeshita | M. Tsujiura | K. Deguchi | H. Takeshita | R. Morimura
[1] K. Hioki,et al. Correlation of preoperative carcinoembryonic antigen levels and prognosis of gastric cancer patients , 1994, Cancer.
[2] Chin-Wen Chi,et al. miR-21 microRNA expression in human gastric carcinomas and its clinical association. , 2008, Anticancer research.
[3] 本山 一夫. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family , 2009 .
[4] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[5] A. Harris,et al. Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma , 2008, British journal of haematology.
[6] L. Sobin,et al. TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.
[7] Robert C. G. Martin,et al. Extended Local Resection for Advanced Gastric Cancer: Increased Survival Versus Increased Morbidity , 2002, Annals of surgery.
[8] S. Lowe,et al. A microRNA polycistron as a potential human oncogene , 2005, Nature.
[9] F. Roviello,et al. Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer. , 2001, American journal of surgery.
[10] V. Narry Kim,et al. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer , 2009, Nucleic acids research.
[11] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[12] E. Ng,et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening , 2009, Gut.
[13] A. Jemal,et al. Global Cancer Statistics , 2011 .
[14] D. Hoon,et al. Circulating nucleic acids in plasma and serum: past, present and future. , 2004, Current opinion in molecular therapeutics.
[15] Xianjun Wang,et al. Detection of let-7a microRNA by real-time PCR in gastric carcinoma. , 2007, World journal of gastroenterology.
[16] D. Carter. TNM Classification of Malignant Tumors , 1998 .
[17] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[18] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[19] W. Filipowicz,et al. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.
[20] William Ignace Wei,et al. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue , 2008, Clinical Cancer Research.
[21] Richard A. Szucs,et al. TNM Classification of Malignant Tumors. 5th ed , 1998 .
[22] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[23] K. C. Chan,et al. Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers , 2007, British Journal of Cancer.
[24] B. Xiao,et al. Differential expression of microRNA species in human gastric cancer versus non‐tumorous tissues , 2009, Journal of gastroenterology and hepatology.
[25] G. Wagner. The Classification of Malignant Tumors , 1987, Methods of Information in Medicine.
[26] Jianjun Chen,et al. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression , 2008, Laboratory Investigation.
[27] J. C. Tsang,et al. Circulating nucleic acids in plasma/serum , 2007, Pathology.
[28] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[29] Hansjuerg Alder,et al. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. , 2009, Gynecologic oncology.
[30] X. Chen,et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.
[31] Brock C Christensen,et al. MicroRNA Expression Ratio Is Predictive of Head and Neck Squamous Cell Carcinoma , 2009, Clinical Cancer Research.
[32] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[33] L. Lim,et al. A microRNA component of the p53 tumour suppressor network , 2007, Nature.
[34] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[35] S. Ramaswamy,et al. Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. , 2002, Cancer research.
[36] D. Sidransky,et al. Nucleic acid-based methods for the detection of cancer. , 1997, Science.